Strengthening Families & Communities LLC Purchases 3,946 Shares of Danaher Corporation $DHR

Strengthening Families & Communities LLC grew its holdings in shares of Danaher Corporation (NYSE:DHR) by 2,818.6% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,086 shares of the conglomerate’s stock after buying an additional 3,946 shares during the quarter. Strengthening Families & Communities LLC’s holdings in Danaher were worth $832,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. WFA of San Diego LLC bought a new stake in Danaher during the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the second quarter valued at approximately $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher in the 3rd quarter worth $28,000. Red Tortoise LLC increased its stake in shares of Danaher by 175.0% during the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after buying an additional 98 shares during the period. Finally, Tripletail Wealth Management LLC bought a new stake in shares of Danaher in the third quarter valued at about $31,000. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of NYSE DHR opened at $223.63 on Tuesday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $242.80. The business’s 50 day moving average price is $230.53 and its 200 day moving average price is $214.46. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The firm has a market cap of $157.96 billion, a P/E ratio of 44.37, a P/E/G ratio of 2.95 and a beta of 0.91.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 EPS for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same period in the previous year, the business posted $2.14 EPS. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. On average, sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Argus set a $265.00 price target on shares of Danaher in a research report on Wednesday, January 14th. Wells Fargo & Company boosted their price target on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. HSBC raised their price objective on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research report on Monday, December 1st. Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Finally, Evercore ISI restated an “outperform” rating and issued a $254.00 target price on shares of Danaher in a research note on Wednesday, January 28th. Twenty investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $252.32.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares of the company’s stock, valued at $552,352.50. This represents a 66.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Teri List sold 3,298 shares of Danaher stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,248 shares of company stock valued at $6,609,663 in the last 90 days. 11.20% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.